Thurston Springer Miller Herd & Titak Inc. Purchases 294 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Thurston Springer Miller Herd & Titak Inc. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,930 shares of the medical device company’s stock after buying an additional 294 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in Cooper Companies were worth $545,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in COO. Point72 Asset Management L.P. raised its stake in Cooper Companies by 480.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after acquiring an additional 776,140 shares during the period. Victory Capital Management Inc. increased its stake in shares of Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. Magnetar Financial LLC bought a new stake in shares of Cooper Companies in the second quarter valued at approximately $63,822,000. JPMorgan Chase & Co. lifted its stake in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter valued at approximately $46,727,000. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on COO. Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup decreased their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Finally, Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Trading Up 1.8 %

Shares of Cooper Companies stock opened at $90.68 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The firm has a market cap of $18.10 billion, a PE ratio of 46.50, a PEG ratio of 2.40 and a beta of 0.99. The company has a 50 day simple moving average of $97.24 and a two-hundred day simple moving average of $98.95.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.87 earnings per share. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.